Stay updated on RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial
Sign up to get notified when there's something new on the RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial page.

Latest updates to the RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.2%
- Check23 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check52 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check59 days agoChange DetectedDifference0.3%
- Check66 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a detailed study on the efficacy of RTXM83 for treating Diffuse Large B-cell Lymphoma, including its methodology, inclusion and exclusion criteria, and collaborator information. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference23%
Stay in the know with updates to RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial page.